# Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration

> **NCT00793767** · NA · COMPLETED · sponsor: **Aarhus University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Insulin Sensitivity

## Interventions

- **DRUG:** erythropoietin
- **DRUG:** placebo (saline)

## Key facts

- **NCT ID:** NCT00793767
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-04
- **Final completion:** —
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2009-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00793767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00793767, "Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00793767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*